Mizuho initiated coverage of Align Technology (ALGN) with an Outperform rating and $295 price target Nearly every subsegment of the global dental/orthodontic market has witnessed softness over the last two years, but greater economic sensitivity of clear aligners has led to a greater delta of growth deceleration for Align than seen at other companies, notes the analyst. However, this means that as the industry potentially rebounds, Align is likely poised for the greatest lift in revenue and profit growth within the peer group in 2025-2027, the analyst argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align receives CE Mark in Europe for Invisalign Palatal Expander System
- Align Technology announces $275M open market repurchase
- Align Tech Announces $275 Million Stock Buyback Plan
- Early notable gainers among liquid option names on October 24th
- Align Technology price target lowered to $280 from $310 at Morgan Stanley